Viewing Study NCT06397651



Ignite Creation Date: 2024-05-06 @ 8:27 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06397651
Status: RECRUITING
Last Update Posted: 2024-05-17
First Post: 2024-04-25

Brief Title: A Randomised Controlled Trial to Evaluate the Impact of Complement Theorys Live 11 Exercise Coaching and Personalised Digital Application on Cancer Survivors Cost of Care
Sponsor: Complement Theory Inc
Organization: Complement Theory Inc

Study Overview

Official Title: A Decentralized Double-blinded Randomized 18 Month Parallel-group Superiority Study to Evaluate the Impact of Complement Theorys Live 11 Exercise Coaching and Personalized Digital Application on Cancer Survivors Cost of Care
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: A Decentralized Double-blinded Randomized 18 month Parallel-group Superiority Study to evaluate the impact of Complement Theorys Live 11 Exercise Coaching and Personalized Digital Application on Cancer Survivors Cost of Care
Detailed Description: The randomized controlled trial RCT aims to evaluate the efficacy of Complement Theorys CT personalized and interactive evidence-backed lifestyle program in reducing healthcare costs and improving health outcomes for survivors across all major cancer types

Distinct from conventional interventions CTs program offers live 11 coaching through a mobile app concentrating on Exercise and Meditation and is enriched with evidence-based advice on Diet Sleep and comprehensive lifestyle modifications This trial is pivotal in assessing the programs effectiveness against an active comparator- expert-recommended lifestyle modification resources suitable for cancer survivors--to isolate the impact of coaching and personalization

The primary objective is to investigate whether CTs novel approach can more effectively reduce healthcare utilization through reduction of hospitalizations urgent care visits and outpatient visits Furthermore the trial seeks to measure adherence to treatment and significant health outcomes including improvements in Quality of Life Scores QoLS to provide a holistic evaluation of the programs impact on patient care and well-being As an exploratory effort the trial will also measure cancer progression recurrence in Prostate and Colorectal cancer survivors alone

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None